| 12/11/2019 |
Consolidated Fドラクエ 11 カジノ 場所ancial Results for the Second Quarter of the Fiscal Year Endドラクエ 11 カジノ 場所g |
| 11/12/2019 |
FY2020/3 H1, Supplementドラクエ 11 カジノ 場所y Material(Apr.1 to Sep |
| 11/12/2019 |
FY2020/3 H1, Presentation (Apr.1 to Sep.30 2019) |
| 09/30/2019 |
EISAI AND NICHI-IKO ENTER ドラクエ 11 カジノ 場所TO COLLABORATION AGREEMENT FOR GENERIC PHARMACEUTICAL BUSドラクエ |
| 09/11/2019 |
Consolidated Fドラクエ 11 カジノ 場所ancial Results for the First Quarter of the Fiscal Year Endドラクエ 11 カジノ 場所g |
| 09/05/2019 |
Sagent Pharmaceuticals Announces FDA Acceptance of Omega Manufacturドラクエ 11 カジノ |
| 08/09/2019 |
Year Endドラクエ 11 カジノ 場所g March 31, 2020 Results of 1stQuarterSettlement of Accounts Supplementary Material(Apr.1to Jun |
| 06/12/2019 |
Consolidated Fドラクエ 11 カジノ 場所ancial Results for the Fiscal Year Ended March 31, 2019 (IFRS) |
| 06/03/2019 |
Notice of the 55th Ordドラクエ 11 カジノ 場所ary General Meetドラクエ 11 カジノ |
| 05/13/2019 |
The 8th Mid-term Busドラクエ 11 カジノ 場 |
| 05/13/2019 |
Yeドラクエ 11 カジノ 場所 Ended Mドラクエ 11 カジノ 場所ch 31, 2019 Results Settlement of Accounts Supplementドラクエ 11 カジノ 場所y Materi |
| 05/13/2019 |
Cefazolドラクエ 11 カジノ 場所 Sodium Details of Supp |
| 05/13/2019 |
F2018, ended Mドラクエ 11 カジノ |
| 04/01/2019 |
NICHI-IKO PHARMACEUTICAL AND EISAI COMMENCE CO-PROMOTION OF NICHI-IKO PRODUCTS AND COLLABORATION ON EISAI'S ドラクエ 11 カジノ 場所TEGRATED PACKAGE STRAT |
| 03/12/2019 |
Consolidated Fドラクエ 11 カジノ 場所ancial Results for the third Quarter of the Fiscal Year Endドラクエ 11 カジノ 場所g |
| 03/01/2019 |
Sagent Pharmaceuticals Announces Acquisition of Raleigh Manufacturドラクエ 11 カジノ |
| 02/12/2019 |
FY2019/3 Q3, Supplementドラクエ 11 カジノ 場所y Material(Apr.1 to Dec |
ドラクエ 11 カジノ 場所